by at Predictably, Moderna has secured up to $60 million from the (CEPI) to accelerate development of an Ebola “vaccine” amid an ongoing outbreak in eastern Democratic Republic of Congo, where there have been 282 confirmed cases, 42 deaths, and around 1,100 suspected cases, plus nine confirmed cases (one fatal) in Uganda. In case you didn’t know, CEPI is the brainchild of the , and the . This seems a little odd to me considering that Ebola is highly containable and Bundibugyo has a lower CFR ...

Read the original article